SCHEMBL18889752

SCHEMBL18889752

COc1ccc(/C=C(\C#N)c2ccc(OC)c(OC)c2OC)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ EGFR P00533 1/20 0.58
▸ PDGFRB P09619 1/20 0.58
▸ PDGFRA P16234 1/20 0.58
▸ TUBB4A P04350 4/20 0.55
▸ TUBB P07437 4/20 0.55
▸ TUBA3C P0DPH7 4/20 0.55
▸ TUBA1B P68363 4/20 0.55
▸ TUBA4A P68366 4/20 0.55
▸ TUBB4B P68371 4/20 0.55
▸ TUBB3 Q13509 4/20 0.55
▸ TUBB2A Q13885 4/20 0.55
▸ TUBB8 Q3ZCM7 4/20 0.55
▸ TUBA3E Q6PEY2 4/20 0.55
▸ TUBA1A Q71U36 4/20 0.55
▸ TUBA1C Q9BQE3 4/20 0.55
▸ TUBB6 Q9BUF5 4/20 0.55
▸ TUBB2B Q9BVA1 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18889754 1.00 RECQL (0.58) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL8127820 0.86 TUBB4A (0.51) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL8130608 0.84 MEN1 (0.55) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL8133470 0.83 TUBB1 (0.48) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL18889659 0.82 TUBB4A (0.80) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL6431369 0.81 TUBB4A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL6431367 0.81 TUBB4A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL4996875 0.80 RECQL (0.67) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL12507433 0.80 RECQL (0.67) RECQLSMN1; SMN2HIF1AEGFRPDGFRB
SCHEMBL4996892 0.80 RECQL (0.67) RECQLSMN1; SMN2HIF1AEGFRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708310-B2 Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof CHINA MEDICAL UNIVERSITY (TW) 2017-07-18 — — US disclosed
US-20170152257-A1 PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID HAVING A HYDROXYL GROUP ON THE PHENANTHRENE RING THEREOF, PREPARATION METHOD AND USE THEREOF CHINA MEDICAL UNIVERSITY (TW) 2017-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152257-A1 PHENANTHROINDOLIZIDINE AND PHENANTHROQUINOLIZIDINE ALKALOID HAVING A HYDROXYL GROUP ON THE PHENANTHRENE RING THEREOF, PREPARATION METHOD AND USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAH, HIPK4 RECQL 1774/4885SMN1; SMN2 4850/4885HIF1A 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback